Fever, a nonspecific acute-phase response, has been associated with improve
d survival and shortened disease duration in infections, but the mechanisms
of these beneficial responses are poorly understood. We previously reporte
d that increasing core temperature of bacterial endotoxin (LPS)-challenged
mice to the normal febrile range modified expression of tumor necrosis fact
or alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), and IL-6, three cytok
ines critical to mounting an initial defense against microbial pathogens, b
ut survival was not improved in the warmer animals. We speculated that our
inability to show a survival benefit of optimized cytokine expression in th
e warmer animals reflected our use of LPS, a nonreplicating agonist, rather
than an infection with viable pathogens. The objective of this study was t
o determine if increasing murine core temperature altered cytokine expressi
on and improved survival in an experimental bacterial peritonitis model. We
showed that housing mice at 35.5 degrees C rather than 23 degrees C increa
sed core temperature from 36.5 to 37.5 degrees C to 39.2 to 39.7 degrees C,
suppressed plasma TNF-alpha expression for the initial 48 h, delayed gamma
interferon expression, improved survival, and reduced the bacterial load i
n mice infected with Klebsiella pneumoniae peritonitis. We showed that the
reduced bacterial load was not caused by a direct effect on bacterial proli
feration and probably reflected enhanced host defense. These data suggest t
hat the increase in core temperature that occurs during bacterial infection
s is essential for optimal antimicrobial host defense.